Heller Ehrman - Life Sciences

08.22.2008
New Case: Important Consequences for Open Source and Commercial Software Licensing More »
05.03.2008
How China's Courts Determine Damages in Patent Infringement Cases More »
03.17.2008
Understanding How the FCPA Affects Pharma Interests in China More »
02.15.2008
Heparin Problems Renew Questions Of Liability More »
01.31.2008
Client Alert: Selected Customs And Export Control Developments For 2008 More »
01.07.2008
Managing Risks Under U.S. Import- And Export-Related Laws More »

10.08.2007
Insider Analysis: Pharmaceutical Outsourcing To China – Some Legal Issues More »
08.13.2007
Learned Intermediary Doctrine More »
07.17.2007
Insider Analysis: Establishing Pharmaceutical R&D Centers in China/Legal Issues More »
07.11.2007
Commerce Department Issues New Regulation for Exports to China More »
03.2007
An Expanded License to Sue More »
01.29.2007
MedImmune v. Genentech ruling creates patent licensing uncertainty More »

BIO Investor Forum
More »